Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease
Condition(s):Diabetic Nephropathies; Diabetic Kidney DiseaseLast Updated:December 7, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Diabetic Nephropathies; Diabetic Kidney DiseaseLast Updated:December 7, 2020Unknown status
Condition(s):Pancreatic CancerLast Updated:February 2, 2024Not yet recruiting
Condition(s):Metabolic SyndromeLast Updated:October 9, 2015Completed
Condition(s):Aneurysmal Subarachnoid HemorrhageLast Updated:September 5, 2017Unknown status
Condition(s):Alzheimer’s DiseaseLast Updated:July 6, 2023Recruiting
Condition(s):ParkinsonismLast Updated:September 13, 2023Recruiting
Condition(s):Avascular Necrosis of the Talus; Talar Osteochondral Defect of Ankle; Talar DysfunctionLast Updated:March 15, 2024Not yet recruiting
Condition(s):Orthostatic Hypotension; Alzheimer DiseaseLast Updated:January 5, 2024Recruiting
Condition(s):Avascular Necrosis of the TalusLast Updated:November 13, 2023Recruiting
Condition(s):ObesityLast Updated:December 16, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.